Related Experiment Video

Updated: Jul 10, 2026

High-Density Lipoprotein-Specific Phospholipid Efflux Assay
07:08

High-Density Lipoprotein-Specific Phospholipid Efflux Assay

Published on: September 30, 2025

Targeting high-density lipoprotein cholesterol in the management of cardiovascular disease

Michael H Davidson1

  • 1Pritzker School of Medicine, University of Chicago, Chicago, IL, USA. michaeldavidson@radiantresearch.com

The American Heart Hospital Journal
|November 6, 2007
PubMed

Insights

Low-density lipoprotein (LDL) reduction alone is insufficient for preventing coronary heart disease (CHD). Increasing high-density lipoprotein (HDL) cholesterol is crucial for optimizing CHD outcomes and managing cardiovascular risk effectively.

Area of Science:

  • Cardiovascular Medicine
  • Lipid Metabolism
  • Preventive Cardiology

Background:

  • Established link between low-density lipoprotein (LDL) cholesterol and coronary heart disease (CHD).
  • Traditional CHD management focuses on LDL reduction and overall lipid profiles.
  • LDL reduction alone is insufficient for preventing CHD events.

Purpose of the Study:

  • To review strategies for targeting high-density lipoprotein (HDL) cholesterol.
  • To optimize outcomes in patients with coronary heart disease (CHD).
  • To highlight the importance of increasing HDL cholesterol levels.

Main Methods:

  • Literature review of studies on HDL cholesterol and CHD.
  • Analysis of current treatment guidelines and emerging strategies.
  • Synthesis of evidence regarding HDL-targeting therapies.

Main Results:

  • HDL cholesterol plays a critical role in cardiovascular risk beyond LDL.
  • Increasing HDL cholesterol is a necessary component of comprehensive CHD management.
  • Various therapeutic approaches aim to raise HDL levels.

Conclusions:

  • Effective CHD management requires a dual approach: reducing LDL and increasing HDL cholesterol.
  • Targeting HDL cholesterol offers a promising avenue for further reducing cardiovascular events.
  • Future research should focus on novel HDL-modulating therapies.

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Lipids: Dietary Sources and Requirements01:18

Lipids: Dietary Sources and Requirements

Lipids are an essential component of a balanced human diet. Triglycerides, which make up the majority of dietary lipids, are found in both saturated fats—commonly present in meat, dairy products, and certain tropical plants like coconut, and hydrogenated oils such as margarine and baking shortenings (trans fats)—and unsaturated fats, which are abundant in seeds, nuts, olive oil, and most vegetable oils. The main sources of cholesterol include egg yolks, various meats and organ meats, shellfish,...